Vaccination may reduce the risk of long COVID-19

Pfizer's Covid Drug Paxlovid May Reduce the Risk of Developing Long Covid, Study Says

People who took Pfizer’s antiviral treatment Paxlovid shortly after infection saw a 26% lower risk of long Covid compared with those who didn’t, the study...

Covid: Vaccination halves risk of long Covid, study shows

Being vaccinated against the SARS-CoV-2 virus halves people's risk of developing long Covid, according to the largest study of its kind. The research, published in the journal JAMA Internal Medicine, reveals the risk factors associated with developing the long-term symptoms of Covid-19.

Vaccination may reduce the risk of long COVID-19

The study also shows that severe illness during the acute phase as reflected by the need for hospitalisation or admission to an intensive care unit, is also associated with the development of long COVID.

Vaccination halves risk of long COVID, study shows

Vaccination halves risk of long COVID, study shows Being vaccinated against the SARS-CoV-2 virus halves people's risk of developing long COVID, according to the largest study of its kind.The research, published in the journal JAMA Internal Medicine, reveals the risk factors associated with developing the long-term symptoms of COVID-19.The study, which includes more than 860,000 patients also found that overweight people, women, smokers and thos…

Vaccination halves risk of long Covid: Study – THIP Media

London, March 24 (IANS) Being vaccinated against Covid halves people's risk of developing long Covid, according to new research conducted on more than